Navigation Links
Stallergenes Moves to the Cloud With Veeva CRM
Date:10/11/2011

BARCELONA, Spain, October 11, 2011 /PRNewswire/ --

Leading Specialty Pharmaceutical Company Consolidates Four On-Premise CRM Systems into One

Stallergenes, the world leader in sublingual immunotherapy, has selected Veeva CRM to replace its existing conventional on-premise systems to support its worldwide sales force. Veeva CRM is today's #1 selling cloud-based CRM solution for the global pharmaceutical and biotech industry.

Previously, Stallergenes utilised four different Customer Relationship Management (CRM) systems across 14 countries before selecting Veeva CRM.  Veeva was chosen from a pool of CRM vendors to support Stallergenes growing international operations and new sales force effectiveness initiative. According to the company, Veeva CRM proved to be the most innovative and robust solution, enabling improved customer targeting, increased understanding of customer behaviour and enhanced coordination of data between the field force, medical affairs and marketing teams.


"We needed a system that could support rapid growth across borders," said Cyril Tavier, vice president, international operations at Stallergenes. "Veeva's cloud-based solution is the gold standard in new, innovative technologies, allowing the high level of flexibility and scalability we need to support our expanding operations globally. Veeva is a perfect match for our company, and supports our mission as an industry innovator."

Thierry Grehaigne, vice president, information technologies at Stallergenes added, "We wanted a single, comprehensive CRM solution that would be intuitive and easy to use for all users across regions and that could keep pace with changing technology. Veeva had it all."

Stallergenes will also be rolling out Veeva's leading iPad application, iRep, to users in major European markets. Veeva iRep is the first integrated CLM/CRM application designed specifically for the Apple iPad. Veeva redesigned its CRM application to
'/>"/>

SOURCE Veeva Systems
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
2. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
3. Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet
4. Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
5. STALLERGENES: Persistent Efficacy Demonstrated After a Year on Actair(R) Followed by a Second Treatment-Free Year
6. STALLERGENES: Excellent 1st Half-Year 2010 Performance
7. Arriva Pharmaceuticals Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT Replacement Therapy for Hereditary Emphysema
8. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
9. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
10. Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
11. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... /PRNewswire-iReach/ -- It is no secret that Americans have an ... obese gyms and supplement companies are in line to make ... related to dietary issues and a lack of physical activity ... glandular problem or even a vitamin deficiency. (Photo: ... a lack of vitamin b12 . The vitamin is ...
(Date:5/20/2013)... May 20, 2013   National Community Pharmacists Association ... , RPh, MBA issued the following statement today regarding ... Medicare Part D "preferred pharmacy" drug plans , ... the plan,s lowest advertised co-payments: (Logo:  ... and MedPAC , 16 U.S. Senators ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- Today at American Society ... Christine Ginocchio discussed Specific Technologies blood ... identification of microorganisms producing bloodstream infection. Dr. Ginocchio ... the Division of Infectious Disease Diagnostics at North ... non-sectarian health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ...
Breaking Medicine Technology:USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... 1 InterMune, Inc. (Nasdaq: ITMN ) today announced ... InterMune, will present at the Fourth Annual JMP Securities Healthcare ... 3:30 p.m. EDT. , To access a live ... may log on to the investor relations page of InterMune,s ...
... announced today that it has entered into a binding agreement ... Fovea has a portfolio of three clinical compounds, a unique ... the eye diseases. The deal is valued to a total ... milestone payments related to the progress of the clinical compounds. ...
Cached Medicine Technology:Fovea Pharmaceuticals to be Acquired by sanofi-aventis 2
(Date:5/21/2013)... Adeptia, a leading provider of innovative cloud and ... the featured company in an impact report written and ... Bets on Converged Cloud Integration and Process-Orchestration Suites,” offers ... pricing, customers and competition. , “For organizations ... and process orchestration, especially when price, ease of use ...
(Date:5/21/2013)... , , TUESDAY, May 21 (HealthDay News) -- Depression can ... the changes brought about by the disorder can be ... has found that people with diabetes who are depressed ... having a severe low blood sugar (hypoglycemia) episode that ... diabetes who aren,t depressed. "Depression is a ...
(Date:5/21/2013)... LOUISVILLE, Ky. Grapefruits have long been known ... may revolutionize how medical therapies like anti-cancer drugs ... of Louisville researchers have uncovered how to create ... have discovered how to use them as drug ... Qilong Wang, Ph.D., and their team today (May ...
(Date:5/21/2013)... May 21, 2013 Benefit Express Services, ... medium, and small organizations, will be hosting a free ... team from Findley Davies. The presentation will focus on ... in compliance with new Health Care Reform Requirements. The ... employees. , “Benefit Express regularly hosts free educational ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Dr. Francine Kaufman ... pump she used with her patients in the 1980s: It weighed ... brick.” For the most part, it could only be used in ... 30 years since then, and the advantages are greater as well. ... the outside of the body, often on a belt or a ...
Breaking Medicine News(10 mins):Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4
... enough dairy products, fruits and vegetables in your daily ... new study.// ,Researchers say the findings are important ... triple between 1985 and 2050. Obesity, lack of physical ... for disability, but little is known about the role ...
... reduced risk of brain damage and cerebral palsy by having ... to a recent study. ,Babies that received an ... signs of being at a high risk for brain injury. ... babies are oxygen-deprived instead, researchers say a chemical cascade is ...
... recent study researchers say women who suffer migraines with ... // compared to women who do not have a ... 963 women, 543 of whom had suffered strokes. They ... with visual lines and spots increased the likelihood of ...
... shouldn’t receive steroids to reduce inflammation,// say researchers after ... to those who received a placebo. ,Researchers ... 21 percent of those treated with the drugs died ... treated. According to Dr.Phil Alderson who conducted the study, ...
... by the Norwegian University of Science and Technology, has managed ... ,A small study done using driving simulators to test ... used were dyslexic) by the University found that Dyslexic drivers ... ,Research at the Norwegian University based in Trondheim, asked ...
... is just as good at beating mild to moderate depression ... different exercise programs for people with mild to moderate depression, ... those taking part in aerobic exercises like walking on a ... involved 80 people with mild to moderate depression who were ...
Cached Medicine News:
... unique product series, the VM500, for critical temperature ... freezers. This is a stand alone product, no ... our VM500 solution you can stack the VM500's ... phone line. The VM500 has a built in ...
... is ideally suited to continuously monitor the ... hospitals and blood banks. In addition, ... aspects of the physical plant as well. ... is handled over the hospital's existing LAN. ...
The GelPort XE hand access system combines the technology of the GelSeal® cap with the retraction and protection of the Alexis wound retractor....
... The HandPort Systems non-adhesive sealing ... Hand-Assisted Laparoscopic Surgrery (HALS) procedures, ... grasp, and palpate throughout. Because ... as 6 cm, patients experience ...
Medicine Products: